FIELD: chemistry.
SUBSTANCE: invention relates to novel antitumour compounds of general formula I
, where R1-16 are groups independently selected from hydrogen, protected or unprotected hydroxyl, C1-C24 alkyl, C2-C24 alkenyl, =O and ORa, OCORa; X and Y are C5-C12 alkyl groups which are substituted with one or more C1-C6 alkyl groups, hydroxyl groups and/or tetrahydropyran which can be optionally substituted with an alkyl and/or ORa group; Ra is independently selected from hydrogen and C1-C12 alkyl; and the dotted line denotes a double bond. The invention also relates to a method of producing said compounds, a pharmaceutical composition based on said compounds, having antitumour activity and use of formula I compounds to prepare a medicinal agent for treating cancer.
EFFECT: novel compounds which have cytotoxic activity and can be used to treat cancer are obtained and described.
15 cl, 2 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTI-CANCER STEROID LACTONES UNSATURATED IN POSITION 7(8) | 2011 |
|
RU2572595C2 |
ANTITUMOUR COMPOUNDS | 2008 |
|
RU2528393C9 |
ANTITUMORAL COMPOUNDS | 2008 |
|
RU2489429C2 |
METHOD OF PREVENTING SEXUALLY TRANSMITTED VIRAL DISEASES, MEDICATION, METHOD OF OBTAINING MEDICATION, PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION AND CONDOM | 2010 |
|
RU2560879C2 |
LEUKOTRIENE A4-HYDROLASE INHIBITORS | 2014 |
|
RU2690489C2 |
ANTITUMOUR COMPOUNDS | 2008 |
|
RU2493147C2 |
LEUKOTRIENE A4-HYDROLASE INHIBITORS | 2014 |
|
RU2696559C2 |
2-PHENYLAMINO-3-CYANOPYRAZOLO[1,5-A]PYRIMIDINE, USEFUL AS INHIBITOR OF LEUKOTRIENE A HYDROLASE | 2014 |
|
RU2678196C2 |
ANTICANCER DIHYDROPYRAN-3-ONE COMPOUNDS | 2007 |
|
RU2444519C2 |
SUBSTITUTED AROMATIC DERIVATIVE WITH CONDENSED RINGS AND COMPOSITION INCLUDING IT AND THEIR USE | 2020 |
|
RU2811484C1 |
Authors
Dates
2011-09-10—Published
2006-12-14—Filed